Contamination of infectious RD-114 virus in vaccines produced using non-feline cell lines

Biologicals

Volumn 39, Issue 1, 2011, Pages 33-37

  Yoshikawa, Rokusuke ^a,b   Sato, Eiji ^a   Miyazawa, Takayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Contamination; Endogenous retrovirus; RD 114 virus; Veterinary vaccines

Indexed keywords

BETA GALACTOSIDASE; LIVE VACCINE; VIRUS DNA; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; ENDOGENOUS RETROVIRUS; ENZYME ASSAY; FELINE PANLEUKOPENIA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RD 114 VIRUS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SARCOMA CELL; VACCINE PRODUCTION; VETERINARY MEDICINE; VIRAL CONTAMINATION; VIRUS ATTENUATION; VIRUS ISOLATION;

ANIMALS; BASE SEQUENCE; CATS; CELL LINE; CELL LINE, TUMOR; DOGS; DRUG CONTAMINATION; ENDOGENOUS RETROVIRUSES; HUMANS; MOLECULAR SEQUENCE DATA; PARVOVIRUS, CANINE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE HOMOLOGY, NUCLEIC ACID; VACCINES; VACCINES, ATTENUATED;

CANINE PARVOVIRUS 2; FELIDAE; FELIS CATUS; PARVOVIRUS;

EID: 79551519943     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2010.11.001     Document Type: Article

References (15)

1. Baumann J.G., Gunzburg W.H., Salmons B. CrFK feline kidney cells produce an RD114-like endogenous virus that can package murine leukemia virus-based vectors. J Virol 1998, 72:7685-7687.
2. Fischinger P.J., Peebles P.T., Nomura S., Haapala D.K. Isolation of an RD-114-like oncornavirus from a cat cell line. J Virol 1973, 11:978-985.
3. Okabe H., Gilden R.V., Hatanaka M. RD 114 virus-specific sequences in feline cellular RNA: detection and characterization. J Virol 1973, 12:984-994.
4. Yoshikawa R., Sato E., Igarashi T., Miyazawa T. Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells. J Clin Microbiol 2010, 48:3366-3369.
5. Miyazawa T., Yoshikawa R., Golder M., Okada M., Stewart H., Palmarini M. Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets. J Virol 2010, 84:3690-3694.
6. Miyazawa T. Endogenous retrovirus as potential hazards for vaccines. Biologicals 2010, 38:371-376.
7. Narushima R., Usui T., Ogawa T., Shimazaki T. Detection of infectious RD114 virus in feline live multivalent vaccines and provisional safety evaluation in cats. J Jpn Vet Med Assoc 2010, 63:630-633. [in Japanese with English summary].
8. Stratton M.R., Darling J., Pilkington G.J., Lantos P.L., Reeves B.R., Cooper C.S. Characterization of the human cell line TE671. Carcinogenesis 1989, 10:899-905.
9. Takeuchi Y., Cosset F.L., Lachmann P.J., Okada H., Weiss R.A., Collins M.K. Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell. J Virol 1994, 68:8001-8007.
10. Henderson I.C., Lieber M.M., Todaro G.J. Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology 1974, 60:282-287.
11. Sakaguchi S., Okada M., Shojima T., Baba K., Miyazawa T. Establishment of a LacZ marker rescue assay to detect infectious RD114 virus. J Vet Med Sci 2008, 70:785-790.
12. Reed L.J., Muench H.A. A simple method of estimating fifty percent endpoints. J Hyg (Lond) 1938, 27:493-497.
13. Ghani K., Cottin S., de Campos-Lima P.O., Caron M.C., Caruso M. Characterization of an alternative packaging system derived from the cat RD114 retrovirus for gene delivery. J Gene Med 2009, 11:664-669.
14. Mochizuki M., San Gabriel M.C., Nakatani H., Yoshida M., Harasawa R. Comparison of polymerase chain reaction with virus isolation and haemagglutination assays for the detection of canine parvoviruses in faecal specimens. Res Vet Sci 1993, 55:60-63.
15. Badgett M.R., Auer A., Carmichael L.E., Parrish C.R., Bull J.J. Evolutionary dynamics of viral attenuation. J Virol 2002, 76:10524-10529.